ArticleMolecular cancer therapeutics2021

VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases.

Thomas L Ekstrom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.